None of this lot is likely to move around markets too much upon release.
None of this lot is likely to move around markets too much upon release.
Most Popular
Jump Trading gains equity in Polymarket ($11B valuation) & Kalshi ($9B) for liquidity. Risk: Jump faces a $4B lawsuit.
GT beats revenue but misses EPS badly. Margins up, but sales flat. Is it a buy?
Kalshi volume hit $871M, 20% of sports books. Big wins & losses on prediction markets!
WAT beats Q4 revenue, guides Q1 sales up 82%! But long-term growth & margins raise concerns.
MEDP beats Q4 revenue by 3.3% with 32% YoY growth, but stock dips 3.6%. Valuation check needed.
AMKR beats Q4 revenue by 3% ($1.89B) & guides higher, but inventory days rise.
UPWK beats EPS/EBITDA but guides lower next qtr. Stock drops 22.7%. ARPC up 9.8%.
Must Read